Deep Brain Stimulation-Affected Neurons

Deep Brain Stimulation-Affected Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Deep Brain Stimulation-Affected Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:1001579](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001579)</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Glutamatergic projection</td>
<td>VGLUT2</td>
</tr>
<tr>
<td class="label">GABAergic interneuron</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Parvalbumin+</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">GABAergic projection</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Cholinergic interneuron</td>
<td>ACh</td>
</tr>
<tr>
<td class="label">PV+ fast-spiking</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Relay neurons</td>
<td>VGLUT2</td>
</tr>
<tr>
<td class="label">GABAergic interneurons</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Nucleus reticularis</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>Source</td>
</tr>
<tr>
<td class="label">Dopamine</td>
<td>Striatal terminals</td>
</tr>
<tr>
<td c

Deep Brain Stimulation-Affected Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Deep Brain Stimulation-Affected Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:1001579](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001579)</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Glutamatergic projection</td>
<td>VGLUT2</td>
</tr>
<tr>
<td class="label">GABAergic interneuron</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Parvalbumin+</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">GABAergic projection</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Cholinergic interneuron</td>
<td>ACh</td>
</tr>
<tr>
<td class="label">PV+ fast-spiking</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Relay neurons</td>
<td>VGLUT2</td>
</tr>
<tr>
<td class="label">GABAergic interneurons</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Nucleus reticularis</td>
<td>GABA</td>
</tr>
<tr>
<td class="label">Neurotransmitter</td>
<td>Source</td>
</tr>
<tr>
<td class="label">Dopamine</td>
<td>Striatal terminals</td>
</tr>
<tr>
<td class="label">GABA</td>
<td>GPi/SNr output</td>
</tr>
<tr>
<td class="label">Glutamate</td>
<td>STN output</td>
</tr>
<tr>
<td class="label">Acetylcholine</td>
<td>PPN/Striatum</td>
</tr>
<tr>
<td class="label">Neuron Type</td>
<td>Neurotransmitter</td>
</tr>
<tr>
<td class="label">Cholinergic</td>
<td>ACh</td>
</tr>
<tr>
<td class="label">Glutamatergic</td>
<td>VGLUT2</td>
</tr>
<tr>
<td class="label">GABAergic</td>
<td>GAD67</td>
</tr>
<tr>
<td class="label">Marker</td>
<td>Neuron Type</td>
</tr>
<tr>
<td class="label">VGLUT2</td>
<td>Glutamatergic</td>
</tr>
<tr>
<td class="label">GAD67</td>
<td>GABAergic</td>
</tr>
<tr>
<td class="label">PV</td>
<td>Fast-spiking</td>
</tr>
<tr>
<td class="label">ChAT</td>
<td>Cholinergic</td>
</tr>
<tr>
<td class="label">c-Fos</td>
<td>Activity marker</td>
</tr>
<tr>
<td class="label">Parameter</td>
<td>Range</td>
</tr>
<tr>
<td class="label">Frequency</td>
<td>130-185 Hz</td>
</tr>
<tr>
<td class="label">Amplitude</td>
<td>1-4 V</td>
</tr>
<tr>
<td class="label">Pulse width</td>
<td>60-120 μs</td>
</tr>
</table>

Overview

Deep brain stimulation (DBS) affects diverse neuronal populations through electrical modulation, fundamentally altering pathological network activity in movement disorders, psychiatric conditions, and emerging applications in neurodegenerative diseases. Understanding which neurons are affected and how DBS modulates their activity is critical for optimizing therapeutic outcomes in Parkinson's disease, essential tremor, dystonia, and other conditions.[@lozano2013]

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: cerebral cortex glial cell (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:1001579)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_1001579)
• [OBO Foundry (CL:1001579)](http://purl.obolibrary.org/obo/CL_1001579)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Primary DBS Targets and Affected Neurons

Subthalamic Nucleus (STN)

The STN is the most common DBS target for PD:[@hammond2007]

STN Neuron Physiology:

• Spontaneous firing rate: 20-40 Hz (elevated in PD)
• Burst firing patterns in PD
• Beta oscillation synchronization (13-30 Hz)
• DBS regularizes firing, reduces pathological oscillations

Globus Pallidus Internus (GPi)

GPi DBS affects basal ganglia output neurons:[@anderson2018]

GPi Neuron Characteristics:

• High spontaneous firing rate: 50-80 Hz
• Tonic vs. burst firing modes
• Output to thalamus (VA/VL)
• DBS restores more regular output patterns

Ventral Intermediate Thalamus (Vim)

Vim DBS primarily affects thalamocortical relay neurons:[@hua2005]

Vim Neuron Properties:

• T-type calcium channel burst firing
• Cerebellar afferent integration
• Motor cortex projection
• Essential for tremor generation circuit

DBS Mechanisms of Action

Neuronal Modulation

DBS affects neurons through multiple mechanisms:[@mcintyre2010]

• Depolarization block of axons near electrode
• Activation of passing axons
• Modulation of terminal release

• Disruption of pathological oscillations
• Information lesion hypothesis
• Restoration of information flow

• Long-term synaptic changes
• Structural remodeling
• Neurogenesis in some regions

Beta Oscillation Suppression

Excessive beta oscillations in PD networks are normalized by DBS:[@eusebio2009]

Neurotransmitter Release

DBS affects neurotransmitter systems:[@creed2015]

Specific Neuron Populations Affected

Cortical Projection Neurons

STN DBS affects cortical neurons via:[@li2012]

• Hyperdirect pathway: Cortex → STN (glutamatergic)
• Antidromic activation: STN DBS → cortex
• Motor cortex layer 5: Betz cells affected
• Supplementary motor area: Direct pathway modulation

Cerebellar Neurons

Vim DBS affects cerebellar circuitry:[@deuschl2006]

• Dentate nucleus → thalamus projections
• Purkinje cell output modulation
• Cerebellar-thalamo-cortical loop
• Essential for tremor control

Pedunculopontine Nucleus Neurons

PPN DBS targets cholinergic neurons:[@ferraye2010]

PPN Clinical Effects:

• Gait improvement
• Postural stability
• Reduced falls
• Sleep modulation

Disease-Specific Neuronal Effects

Parkinson's Disease

PD DBS affects pathologically altered neurons:[@gradinaru2016]

• STN neurons hyperactive (loss of DA inhibition)
• GPi output neurons overactive
• Beta oscillation emergence
• DBS compensates for DA loss

• Neurons with Lewy bodies may respond differently
• Non-DA systems affected (cholinergic, noradrenergic)
• DBS may spread α-synuclein (theoretical concern)

• Direct pathway underactive
• Indirect pathway overactive
• DBS rebalances these pathways

Dystonia

Dystonia DBS affects motor learning circuits:[@ostrem2008]

• GPi neurons with abnormal firing patterns
• Sensory integration abnormalities
• Plasticity dysregulation
• DBS normalizes sensory-motor integration

Essential Tremor

ET DBS affects tremor-generating circuits:[@benabid2007]

• Olivocerebellar circuitry
• Thalamocortical relay neurons
• GABAergic Purkinje cell dysfunction
• DBS disrupts tremor rhythm

Neurodegenerative Disease Applications

Alzheimer's Disease

Experimental DBS for AD targets:[@laxton2010]

• Fornix DBS: Affects hippocampal-cortical neurons
• Nucleus basalis DBS: Modulates cholinergic basal forebrain
• Entorhinal cortex DBS: Affects memory circuits

• Hippocampal CA1 neurons
• Medial septum cholinergic neurons
• Entorhinal cortex stellate cells

Huntington's Disease

HD DBS targets:[@moro2017]

• GPi: Affects output neurons
• STN: Modulates glutamatergic output
• Targets chorea and behavioral symptoms

Molecular Markers of DBS-Affected Neurons

Clinical Considerations

Electrode Placement

Precise targeting affects which neurons are stimulated:[@zaidel2010]

• Dorsal STN: Motor benefit, fewer side effects
• Ventral STN: Cognitive/affective effects
• Anterior STN: Limbic effects

Programming Parameters

Stimulation parameters affect neuronal responses:[@rizzone2001]

Side Effect Mechanisms

Adverse effects from stimulation of non-target neurons:[@witt2008]

• Speech dysarthria: Corticobulbar tract stimulation
• Cognitive effects: Limbic STN/cortex
• Mood changes: Serotonergic system
• Weight gain: Hypothalamic effects

Future Directions

Closed-Loop DBS

Adaptive stimulation based on neural activity:[@tinkhauser2017]

• Beta burst detection
• Local field potential feedback
• Optimal timing stimulation
• Reduced side effects

Novel Targets

Emerging DBS applications:[@lscher2023]

• Nucleus basalis for AD
• Locus coeruleus for attention
• Ventral tegmental area for motivation
• Lateral hypothalamus for metabolic effects
• [Parkinson's disease](/diseases/parkinsons-disease) essential tremor
• Glutamatergic Neurons
• Thalamocortical Relay Neurons
• Hippocampal CA1 neurons

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
• [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)

Pathway Diagram

The following diagram shows the key molecular relationships involving Deep Brain Stimulation-Affected Neurons discovered through SciDEX knowledge graph analysis: